326 related articles for article (PubMed ID: 23985420)
1. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination.
van Wijk N; Broersen LM; de Wilde MC; Hageman RJ; Groenendijk M; Sijben JW; Kamphuis PJ
J Alzheimers Dis; 2014; 38(3):459-79. PubMed ID: 23985420
[TBL] [Abstract][Full Text] [Related]
2. Nutritional approaches in the risk reduction and management of Alzheimer's disease.
Mi W; van Wijk N; Cansev M; Sijben JW; Kamphuis PJ
Nutrition; 2013 Sep; 29(9):1080-9. PubMed ID: 23756280
[TBL] [Abstract][Full Text] [Related]
3. Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.
Engelborghs S; Gilles C; Ivanoiu A; Vandewoude M
Acta Clin Belg; 2014; 69(1):17-24. PubMed ID: 24635394
[TBL] [Abstract][Full Text] [Related]
4. The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer's disease?
Rasmussen J
Clin Interv Aging; 2019; 14():1481-1492. PubMed ID: 31616139
[TBL] [Abstract][Full Text] [Related]
5. The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study.
de Waal H; Stam CJ; Lansbergen MM; Wieggers RL; Kamphuis PJ; Scheltens P; Maestú F; van Straaten EC
PLoS One; 2014; 9(1):e86558. PubMed ID: 24475144
[TBL] [Abstract][Full Text] [Related]
6. A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AβPPswe/PS1dE9 mice.
Broersen LM; Kuipers AA; Balvers M; van Wijk N; Savelkoul PJ; de Wilde MC; van der Beek EM; Sijben JW; Hageman RJ; Kamphuis PJ; Kiliaan AJ
J Alzheimers Dis; 2013; 33(1):177-90. PubMed ID: 22914588
[TBL] [Abstract][Full Text] [Related]
7. High Content Analysis of Hippocampal Neuron-Astrocyte Co-cultures Shows a Positive Effect of Fortasyn Connect on Neuronal Survival and Postsynaptic Maturation.
van Deijk AF; Broersen LM; Verkuyl JM; Smit AB; Verheijen MHG
Front Neurosci; 2017; 11():440. PubMed ID: 28824363
[TBL] [Abstract][Full Text] [Related]
8. Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease.
Rijpma A; Meulenbroek O; van Hees AM; Sijben JW; Vellas B; Shah RC; Bennett DA; Scheltens P; Olde Rikkert MG
Alzheimers Res Ther; 2015; 7(1):51. PubMed ID: 26213579
[TBL] [Abstract][Full Text] [Related]
9. Specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats.
Cansev M; van Wijk N; Turkyilmaz M; Orhan F; Sijben JW; Broersen LM
Neurobiol Aging; 2015 Jan; 36(1):344-51. PubMed ID: 25146455
[TBL] [Abstract][Full Text] [Related]
10. Souvenaid®: a new approach to management of early Alzheimer's disease.
Ritchie CW; Bajwa J; Coleman G; Hope K; Jones RW; Lawton M; Marven M; Passmore P
J Nutr Health Aging; 2014 Mar; 18(3):291-9. PubMed ID: 24626757
[TBL] [Abstract][Full Text] [Related]
11. Improved spatial learning strategy and memory in aged Alzheimer AβPPswe/PS1dE9 mice on a multi-nutrient diet.
Wiesmann M; Jansen D; Zerbi V; Broersen LM; Garthe A; Kiliaan AJ
J Alzheimers Dis; 2013; 37(1):233-45. PubMed ID: 23803297
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of synaptic dysfunction in Alzheimer's disease.
Masliah E
Histol Histopathol; 1995 Apr; 10(2):509-19. PubMed ID: 7599445
[TBL] [Abstract][Full Text] [Related]
13. Utility of imaging for nutritional intervention studies in Alzheimer's disease.
de Wilde MC; Kamphuis PJ; Sijben JW; Scheltens P
Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S59-69. PubMed ID: 21816137
[TBL] [Abstract][Full Text] [Related]
14. Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.
Cummings J; Scheltens P; McKeith I; Blesa R; Harrison JE; Bertolucci PH; Rockwood K; Wilkinson D; Wijker W; Bennett DA; Shah RC
J Alzheimers Dis; 2017; 55(3):1131-1139. PubMed ID: 27767993
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
Kidd PM
Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
[TBL] [Abstract][Full Text] [Related]
16. Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease.
Monteiro-Cardoso VF; Oliveira MM; Melo T; Domingues MR; Moreira PI; Ferreiro E; Peixoto F; Videira RA
J Alzheimers Dis; 2015; 43(4):1375-92. PubMed ID: 25182746
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study.
Olde Rikkert MG; Verhey FR; Blesa R; von Arnim CA; Bongers A; Harrison J; Sijben J; Scarpini E; Vandewoude MF; Vellas B; Witkamp R; Kamphuis PJ; Scheltens P
J Alzheimers Dis; 2015; 44(2):471-80. PubMed ID: 25322923
[TBL] [Abstract][Full Text] [Related]
18. Synaptic degeneration in Alzheimer's disease.
Arendt T
Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859
[TBL] [Abstract][Full Text] [Related]
19. Dysfunctional synapse in Alzheimer's disease - A focus on NMDA receptors.
Mota SI; Ferreira IL; Rego AC
Neuropharmacology; 2014 Jan; 76 Pt A():16-26. PubMed ID: 23973316
[TBL] [Abstract][Full Text] [Related]
20. Synaptogenesis: Modulation by Availability of Membrane Phospholipid Precursors.
Cansev M
Neuromolecular Med; 2016 Sep; 18(3):426-40. PubMed ID: 27250850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
